M6P Therapeutics is developing the next-generation enzyme replacement and gene therapies for lysosomal storage disorders.  We have discovered a novel method for significantly increasing mannose-6-phosphate phosphorylation of various lysosomal enzymes.  This allows for markedly improved enzyme delivery to target tissues and promises improved clinical outcomes.

Biotechnology

Health Care

Life Sciences

Therapeutics

M6P Therapeutics

M6P Therapeutics' headquarters in St Louis, United States

Pawel Krysiak

Kinan Bachour

Russell Gotschall

Lin Liu

Gavin Maitland

Eric Grinstead

Description

People (3)

Kinan Bachour

Catherine Foulon

Robert Anthony Zivolich

Jobs